Search research articles
Contact Us
Filters
Showing results (321-330 of 436) with videos related to
Page
of 44
Sort By:
The Lancet. Oncology
|
October 4, 2015
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
Elias Jabbour, Hagop Kantarjian, Farhad Ravandi, et al.
Hematological Oncology
|
August 29, 2018
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome
Christopher B Benton, Kelly S Chien, Ayalew Tefferi, et al.
Nature Medicine
|
May 26, 2022
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
Andy G X Zeng, Suraj Bansal, Liqing Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2015
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Naval Daver, Yanis Boumber, Hagop Kantarjian, et al.
Blood
|
September 19, 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML
Reeja Raj, Samanta Catueno, Amber Gibson, et al.
British Journal of Haematology
|
August 23, 2023
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Ziyi Li, et al.
Leukemia
|
May 9, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements
Alex Bataller, Hannah E Goulart, Ghayas C Issa, et al.
Cancer
|
October 4, 2016
Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease
Ghayas C Issa, Hagop M Kantarjian, C Cameron Yin, et al.
American Journal of Hematology
|
November 12, 2020
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes
Koji Sasaki, Elias J Jabbour, Farhad Ravandi, et al.
Cancer
|
June 28, 2021
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy
Sangeetha Venugopal, Mahran Shoukier, Marina Konopleva, et al.
Page
of 44
Search research articles
Search
Showing results (321-330 of 436) with videos related to
Sort By:
Page
of 44
The Lancet. Oncology
|
October 4, 2015
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
Elias Jabbour, Hagop Kantarjian, Farhad Ravandi, et al.
Hematological Oncology
|
August 29, 2018
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome
Christopher B Benton, Kelly S Chien, Ayalew Tefferi, et al.
Nature Medicine
|
May 26, 2022
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
Andy G X Zeng, Suraj Bansal, Liqing Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2015
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Naval Daver, Yanis Boumber, Hagop Kantarjian, et al.
Blood
|
September 19, 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML
Reeja Raj, Samanta Catueno, Amber Gibson, et al.
British Journal of Haematology
|
August 23, 2023
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Ziyi Li, et al.
Leukemia
|
May 9, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements
Alex Bataller, Hannah E Goulart, Ghayas C Issa, et al.
Cancer
|
October 4, 2016
Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease
Ghayas C Issa, Hagop M Kantarjian, C Cameron Yin, et al.
American Journal of Hematology
|
November 12, 2020
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes
Koji Sasaki, Elias J Jabbour, Farhad Ravandi, et al.
Cancer
|
June 28, 2021
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy
Sangeetha Venugopal, Mahran Shoukier, Marina Konopleva, et al.
Page
of 44